Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive study

Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive study

Introduction: Ezrin, also known as cytovillin, is a member of the ERM family of protein. Ezrin cross-links actin filament with the plasma membrane. They are involved in the formation of microvilli, cell–cell adhesion, maintenance of cell shape, cell motility, and membrane trafficking. Recent analysi...

Full description

Bibliographic Details
Main Authors:	Raghini Mohanraj, Pratibha Ramani, Priya Premkumar, Anuja Natesan, Herald J Sherlin, Gheena Sukumaran
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Journal of Pharmacy and Bioallied Sciences
Subjects:	Cytovillin ezrin immunohistochemistry leukoplakia oral potentially malignant disorders oral submucous fibrosis
Online Access:	http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2017;volume=9;issue=5;spage=205;epage=210;aulast=Mohanraj

Similar Items

Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis
by: Sushant S Kamat, et al.
Published: (2013-01-01)

Expression of survivin in oral potentially malignant disorders: An immunohistochemical study
by: Venkatraman R Rajanna, et al.
Published: (2020-01-01)

A quantitative expression of Ki-67 to evaluate malignant transformation rate in potentially malignant disorders
by: Mani D Chitipothu, et al.
Published: (2018-01-01)

Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer
by: Jayanthi Palani, et al.
Published: (2011-01-01)

Role of dermatoglyphics in malignant and potentially malignant disorders of the oral cavity: A cross-sectional study
by: Deepa Jatti, et al.
Published: (2014-01-01)

GIS to Explore the Geographical Mysteries of Oral Cancer: Geospatial Distribution of Patients Diagnosed with Oral Potentially Malignant Disorders at the University Dental Hospital Peradeniya
by: Isuru Athukorala, et al.
Published: (2022-02-01)

Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer
by: Pratima Kumari, et al.
Published: (2022-04-01)

Determining the probability of malignant transformation of tobacco-induced oral leukoplakia using tissue p53 as a prognostic marker – A cross-sectional study
by: Bhargavi Ramesh, et al.
Published: (2022-01-01)

Diagnostic Accuracy of Chemiluminescence for Oral Potentially Malignant Disorders: A Systematic Review and Meta-analysis
by: Amar Kumar Shaw, et al.
Published: (2022-07-01)

Expression of CD 68, CD 45 and human leukocyte antigen-DR in central and peripheral giant cell granuloma, giant cell tumor of long bones, and tuberculous granuloma: An immunohistochemical study
by: Anoop Kumar, et al.
Published: (2015-01-01)

Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis
by: Naga Jyothi Meka, et al.
Published: (2015-09-01)

Role of Digital and Palmar Dermatoglyphics in Early Detection of Oral Leukoplakia, Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patients
by: N Lakshmana, et al.
Published: (2016-01-01)

Malignant transformation rate of oral leukoplakia: A meta analysis
by: P Ramaswamy, et al.
Published: (2020-01-01)

A study to assess the awareness of adults about precancerous and cancerous lesions and the associated risk factors
by: Arti Dixit, et al.
Published: (2023-01-01)

Association of Oral Melanosis with Soft Tissue Pathologies: A Hospitalbased Observational Study
by: Aarushi Garg, et al.
Published: (2021-11-01)

Epithelial expression of keratinocytes growth factor in oral precancer lesions
by: Sudha Jimson, et al.
Published: (2016-01-01)

Tobacco use, Body Mass Index, and Potentially Malignant Disorders Among petrol fillers in Pimpri-Pune (India): A descriptive study
by: Mamatha G. S. Reddy, et al.
Published: (2014-01-01)

Cyclooxygenase-2 expression in oral precancerous and cancerous conditions and its inhibition by caffeic acid phenyl ester-enriched propolis in human oral epidermal carcinoma KB cells
by: Chiu Hui-Fang, et al.
Published: (2017-01-01)

Prevalence and risk factors for oral potentially malignant disorders in Indian population
by: Amit Kumar Singh, et al.
Published: (2021-01-01)

Potential noninvasive biomarkers for the malignant transformation of oral leukoplakia: A systematic review and meta‐analysis
by: Yan Huang, et al.
Published: (2023-07-01)

Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral submucous fibrosis
by: B Sabarinath, et al.
Published: (2011-01-01)

Oral potentially malignant disorders in older adults: A review
by: Ana Contreras, et al.
Published: (2023-09-01)

Malignant Transformation in Leukoplakia and its Associated Factors in Southern Iran: A Hospital Based Experience
by: Alireza BARFI QASRDASHTI, et al.
Published: (2017-07-01)

Role of fluorescence imaging device in screening of oral cancer: A cross-sectional study in chhattisgarh population
by: Shilpa Jain, et al.
Published: (2021-01-01)

Evaluation of Serum C-Reactive Protein Levels in Oral Premalignancies and Malignancies: A Comparative Study
by: Sairam Vankadara, et al.
Published: (2018-11-01)

Correlation of Presence of Candida and Epithelial Dysplasia in Oral Mucosal Lesions
by: Siddharth Kumar Singh, et al.
Published: (2014-10-01)

Transforming growth factor β2 (TGF-β2) in pathogenesis of oral submucous fibrosis: An immunohistochemical study
by: Venkatesh V Kamath, et al.
Published: (2014-01-01)

Diagnosis of oral potentially malignant disorders: Overview and experience in Oceania
by: Alison M. Rich, et al.
Published: (2023-04-01)

Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa
by: Freeda M Selvaraj, et al.
Published: (2022-01-01)

HIF – 1α as a marker of risk assessment for malignant transformation in oral submucous fibrosis: An immunohistochemical study
by: Kanika Sharma, et al.
Published: (2022-01-01)

Influence of site and smoking on malignant transformation in the oral cavity: Is the microbiome the missing link?
by: Sheila Galvin, et al.
Published: (2023-03-01)

Mechanisms and markers of malignant transformation of oral submucous fibrosis
by: Fen Lin, et al.
Published: (2024-01-01)

Immunohistochemical Evaluation of EGFR Expression in Oral Dysplastic and Non-Dysplastic Leukoplakia
by: Nasrollah Saghravanian, et al.
Published: (2023-09-01)

Histochemical and Immunohistochemical Analysis of Collagen Fibers and Microvascular Density in Various Grades of Oral Submucous Fibrosis
by: Savita S Thakkannavar, et al.
Published: (2019-04-01)

Superoxide dismutase and glutathione peroxidase in oral submucous fibrosis, oral leukoplakia, and oral cancer: A comparative study
by: Shubha Gurudath, et al.
Published: (2012-01-01)

Prevalence of Oral Lesions and Nicotine Dependency among Tobacco Users in an Urban Community of Vellore, South India
by: Libin Benance Jacob, et al.
Published: (2022-03-01)

Perspectives for Targeting Ezrin in Cancer Development and Progression
by: Jean Carlos Lipreri da Silva, et al.
Published: (2023-01-01)

Expression of heat shock protein70 in oral submucous fibrosis and oral squamous cell carcinoma: An immunohistochemical study
by: M Thubashini, et al.
Published: (2011-01-01)

Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia
by: Botond Bukovszky, et al.
Published: (2023-06-01)

Immunohistochemical expression of Survivin in oral leukoplakia and oral squamous cell carcinoma
by: Cherukuri Gayathri, et al.
Published: (2017-01-01)